Schedule 13G ownership disclosure
CHROMOCELL THERAPEUTICS CORP
Common Stock, par value $0.0001 per share · CUSIP: 171126105
Event date: 2024-12-13
- Filing-level shares
- 574,187.00
- Percent of class
- 9.53%
- Alexandra Wood (Canada) Inc.
Shares: 574,187.00 · Class: 9.53%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-003922
- Form type
- SCHEDULE 13G
- Filer
- Alexandra Wood (Canada) Inc.
- CIK
- CIK 2052171
- Filed
- Jan 15, 2025
- Reporting period
- Dec 13, 2024
- Description
- Schedule 13G beneficial ownership